Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

Frontiers in Oncology

Oncology

Junqi Liu¹  Yurong Peng¹  Yucheng Fu¹  Chaoyue Xiao¹  Yingzhe Zhang¹  Yue Zeng¹  Fang Wu¹  Yue Pan¹  Zhuo Li²  Guoqing Li³  Yahui Su³ 

[1] Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;The Ophthalmologic Center of the Second Xiangya Hospital, Central South University, Changsha, Hunan, China;XiangYa School of Public Health, Central South University, Changsha, Hunan, China;

关键词: perioperative period perioperative immunotherapy;    neoadjuvant therapies;    immunotherapy;    neoadjuvant immune monotherapy;    adjuvant therapy;    biomarkers;    NSCLC;    lung cancer;   

DOI  :  10.3389/fonc.2023.1163376

 received in 2023-02-10, accepted in 2023-03-20,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Peng, Li, Fu, Pan, Zeng, Liu, Xiao, Zhang, Su, Li and Wu